Search Results for: tilray

Tilray Gets DEA OK To Import Medical Cannabis Study Drug For Clinical Trial At University Of California San Diego Center For Medicinal Cannabis Research

r7_essentialtremor-8col

CANADA: Tilray has announced that the U.S. Drug Enforcement Administration (DEA) has granted approval to import a cannabinoid study drug into the United States from Canada for a clinical trial at the University of California San Diego (UC San Diego) Center for Medicinal Cannabis Research (CMCR) examining its safety, tolerability and efficacy for Essential Tremor (ET). Read the full article…

Tilray Exports 2:100 CBD Oil To The United Kingdom

Tilray exports CBD Oil to the UK

CANADA: Tilray, a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada, was successfully imported into the United Kingdom, to supply a pediatric patient in need.   The changing regulatory measures in the United Kingdom (UK) previously prohibited the Read the full article…

Nova Scotia Liquor Taps Tilray For Adult-Use Cannabis Products

Cannabis will soon be sold in select NSLC stores.

CANADA:  Tilray Canada announced that it has been selected by the Nova Scotia Liquor Corporation to receive an initial purchase order for adult-use cannabis. The purchase order would allow Tilray, one of fourteen cannabis producers selected by NSLC, to supply the province of Nova Scotia with a diverse array of cannabis products in anticipation of the launch of Read the full article…

Tilray Launches Initial Public Offering

Tilray joins Nasdaq

CANADA: Tilray, a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, announced that it has launched an initial public offering of its Class 2 common stock pursuant to a registration statement on Form S-1 previously filed with the United States Securities and Exchange Commission. Tilray has applied to list its common stock on the Nasdaq Global Read the full article…

Tilray Files Application To IPO On Nasdaq

Tilray Inc. Announces Filing of a U.S. Registration Statement and Application for Proposed IPO on Nasdaq

Company has also filed a Canadian Preliminary Prospectus for Proposed IPO, in order to qualify the offering of securities in Canada and to ensure purchasers in Canada are not subject to resale restrictions  CANADA: Tilray, a vertically-integrated and federally-licensed cannabis cultivator, processor and distributor, has announced the filing of a registration statement with the U.S. Securities and Read the full article…

Tilray Announces Appointments To Board Of Directors

New Board members bring expertise in global partnerships, distribution, licensing, public policy, and international business diplomacy

CANADA: Tilray, a global pioneer in cannabis cultivation, processing, distribution and research, today announced the appointment of Rebekah Dopp, a Principal in Global Partnerships at Google; Maryscott “Scotty” Greenwood, CEO of the Canadian American Business Council and a Principal at Dentons; and Christine St.Clare, founder of St.Clare Advisors and formerly a Partner at KPMG, to the Read the full article…

Tilray Launches New High-CBD Cannabis Oil

Tilray_2100

CANADA:  Tilray, a leader in medical cannabis cultivation, distribution, and research, has launched its newest product, Tilray 2:100, a high-CBD cannabis oil. Designed for patients with significant unmet medical need, Tilray 2:100 contains the highest concentration of cannabis-extracted CBD in a medical cannabis product available through Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). Read the full article…

Tilray Shares Preliminary Data From The Largest National Longitudinal Medical Cannabis Patient Study in Canada

Study finds significant reduction in opioid use and improvements in quality of life within first 6 months.

CANADA: Tilray Canada Ltd., a medical cannabis leader committed to advancing scientific knowledge of cannabinoids, shared preliminary data today from the Tilray Observational Patient Study (TOPS), a Tilray-sponsored survey of medical cannabis patients using Tilray products currently underway at 18 different medical clinics in five provinces in Canada. As Canada’s largest national medical cannabis longitudinal study, Read the full article…

Tilray Launches High Park Company to Produce And Distribute Adult-Use Cannabis In Canada

High Park Farms in Enniskillen, Ontario

CANADA: In anticipation of the historic legalization of adult-use cannabis in Canada,  Tilray has announced the creation of wholly-owned subsidiary High Park Company to produce and distribute a broad-based portfolio of cannabis brands and products. As a part of this announcement, the company announced it will be making an investment of up to $10 million in a new facility located in Read the full article…

Tilray Signs Letter Of Intent With Pharmasave

Tilray® Signs Letter of Intent with Pharmasave

CANADA:  Tilray Canada announced that it has entered into a Letter of Intent (LOI) to become a preferred medical cannabis supplier to Pharmasave, the premier independent pharmacy banner in Canada. Subject to changes to Canadian regulations that would allow such distribution, Tilray will supply and distribute Good Manufacturing Practices (GMP) certified Tilray-branded medical cannabis products through Pharmasave pharmacists. Read the full article…